Abrupt Onset of Refractory Heart Failure Associated With Light-Chain Amyloidosis in Hypertrophic Cardiomyopathy

被引:3
|
作者
Tomberli, Benedetta [1 ]
Cappelli, Francesco [2 ]
Perfetto, Federico [2 ]
Olivotto, Iacopo [1 ]
机构
[1] Careggi Univ Hosp, Referral Ctr Cardiomyopathies, Florence, Italy
[2] Careggi Univ Hosp, Reg Amyloid Ctr, Florence, Italy
关键词
D O I
10.1001/jamacardio.2016.3894
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IMPORTANCE The natural history of hypertrophic cardiomyopathy (HCM) is complex and may include progressive heart failure and severe left ventricular dysfunction. When disease progression is abrupt, however, other coexisting diseases should be ruled out. This may be difficult in the case of amyloidosis, which classically mimics HCM. RESULTS We present an example of severe clinical deterioration in a patient with HCM due to superimposed amyloid light-chain amyloidosis. A man in his 70s with a longstanding history of genetically confirmed HCM presented with rapid development of congestive heart failure over 6 months, in sharp contrast to a previously stable, asymptomatic clinical course. He was diagnosed as having the illness in his late 40s after a resuscitated cardiac arrest and regularly followed up on a yearly basis. His most recent electrocardiogram was profoundly changed from previous tracings, with marked and diffuse voltage reduction (QS in V-1-V-3) and inferolateral T-wave inversion. The echocardiogram showed an abrupt increase in the severity of left ventricular (LV) hypertrophy, with a concentric rather than asymmetric appearance, granular sparkling of the myocardium, biatrial enlargement, thickening of the mitral valve leaflets, and interatrial septum and mild pericardial effusion. Severe LV dysfunction with a restrictive LV filling pattern was evident, which is associated with LV outflow tract obstruction loss and right ventricle systolic impairment. Following hospital admission, multiple myeloma was diagnosed and confirmed by bone marrow biopsy and aspiration. Furthermore, abdominal fat aspiration showed amyloid deposition and confirmed the diagnosis of amyloid light-chain amyloidosis. Electrocardiograms, echocardiographic images, and videos presented in this report describe the abrupt and marked evolution of a sarcomeric to infiltrative cardiomyopathy, leading to an ominous outcome in which the patient died despite specific treatment. CONCLUSIONS AND RELEVANCE While progression to the end-stage phase occurs over several years for patients with HCM and can be detected at relatively early stages, the abrupt onset of congestive heart failure is uncommon and should raise suspicion of other, superimposed cardiac diseases.
引用
收藏
页码:94 / 97
页数:4
相关论文
共 50 条
  • [21] PSEUDOXANTHOMA ELASTICUM AND LIGHT-CHAIN AMYLOIDOSIS
    Carlesimo, M.
    Abruzzese, C.
    Cortesi, G.
    Ciccone, A. M.
    Poggi, C.
    Lombardi, M.
    Moscetti, A.
    La Verde, G.
    Mari, E.
    [J]. EUROPEAN JOURNAL OF INFLAMMATION, 2012, 10 (03) : 527 - 530
  • [22] CMR left ventricular strains beyond global longitudinal strain in differentiating light-chain cardiac amyloidosis from hypertrophic cardiomyopathy
    Wang, Fangqing
    Deng, Yan
    Li, Shunjia
    Cheng, Qichao
    Wang, Qing
    Yu, Dexin
    Wang, Qian
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [23] CARDIAC AMYLOIDOSIS AND LIGHT-CHAIN MYELOMA
    MUNARRIZ, B
    MOLINS, C
    BALLESTER, M
    RAMOS, V
    [J]. REVISTA CLINICA ESPANOLA, 1994, 194 (09): : 730 - 730
  • [24] Senile systemic amyloidosis presenting with heart failure - A comparison with light chain-associated amyloidosis
    Ng, B
    Connors, LH
    Davidoff, R
    Skinner, M
    Falk, RH
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (12) : 1425 - 1429
  • [25] The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement
    Dubrey, SW
    Cha, K
    Anderson, J
    Chamarthi, B
    Reisinger, J
    Skinner, M
    Falk, RH
    [J]. QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 1998, 91 (02): : 141 - 157
  • [26] Systemic immunoglobulin light-chain amyloidosis
    Comenzo, Raymond L.
    [J]. CLINICAL LYMPHOMA & MYELOMA, 2006, 7 (03): : 182 - 185
  • [27] Differentiation of light-chain cardiac amyloidosis from hypertrophic cardiomyopathy using myocardial mechanical parameters by velocity vector imaging echocardiography
    Zhang, Lu
    Zhou, Xiao
    Wang, Jing
    Mu, Yang
    Liu, Bohan
    Lv, Wenqing
    Wang, Ye
    Liu, Hongwei
    Liu, Hongbin
    Zhi, Guang
    [J]. INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, 2017, 33 (04): : 499 - 507
  • [28] Differentiation of light-chain cardiac amyloidosis from hypertrophic cardiomyopathy using myocardial mechanical parameters by velocity vector imaging echocardiography
    Lu Zhang
    Xiao Zhou
    Jing Wang
    Yang Mu
    Bohan Liu
    Wenqing Lv
    Ye Wang
    Hongwei Liu
    Hongbin Liu
    Guang Zhi
    [J]. The International Journal of Cardiovascular Imaging, 2017, 33 : 499 - 507
  • [29] OUTCOMES AFTER HEART TRANSPLANTATION FOR LIGHT-CHAIN COMPARED TO TRANSTHYRETIN AMYLOIDOSIS
    Chiu, Leonard
    Farr, Maryjane
    Axsom, Kelly
    Colombo, Paolo
    De Los Santos, Jeffeny
    Garan, A. Reshad
    Goldsmith, Jeff
    Haythe, Jennifer
    Helmke, Stephen
    Horn, Evelyn
    Latif, Farhana
    Lee, Sun Hi
    Lin, Edward
    Naka, Yoshifumi
    Restaino, Susan
    Takayama, Hiroo
    Takeda, Koji
    Teruya, Sergio
    Yuzefpolskaya, Melana
    Maurer, Mathew
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 920 - 920
  • [30] Light-Chain Amyloidosis: The Great Impostor
    Stefani, Georgia
    Kouvata, Evangelia
    Vassilopoulos, George
    [J]. LIFE-BASEL, 2024, 14 (01):